<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156188_doc-4-5-25-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasStartPointer>	"16358"^^<http://www.w3.org/2001/XMLSchema#long> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156188_doc-4-5-25-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasText>	"Dokud nebudou k\u00A0dispozici dal\u0161\u00ED informace, sou\u010Dasn\u00E9 pod\u00E1v\u00E1n\u00ED citalopramu a 5-HT agonist\u016F, jako je sumatriptan a dal\u0161\u00ED triptany, se nedoporu\u010Duje (viz bod 4.4)."@cs .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156188_doc-4-5-25-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasTextChunk>	<http://linked.opendata.cz/resource/sukl/spc/text-chunk/SPC156188_doc-4-5-25-2-16456-16467> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156188_doc-4-5-25-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasEndPointer>	"16516"^^<http://www.w3.org/2001/XMLSchema#long> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156188_doc-4-5-25-2>	<http://salt.semanticauthoring.org/ontologies/sdo#hasOrderNumber>	"2"^^<http://www.w3.org/2001/XMLSchema#int> .
<http://linked.opendata.cz/resource/sukl/spc/sentence/SPC156188_doc-4-5-25-2>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://salt.semanticauthoring.org/ontologies/sdo#Sentence> .